Comparison of neoadjuvant and adjuvant chemotherapy for upper tract urothelial carcinoma in real-world practice: a multicenter retrospective study (Aug, hyad118, 2023)

被引：0
|
作者：
Yayoi, Jikei
机构：
来源：
JAPANESE JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 53卷 / 12期
关键词：
D O I：
10.1093/jjco/hyad129
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1217 / 1217
页数：1
相关论文
共 50 条
  • [41] Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study
    Nakagawa, Tohru
    Komemushi, Yoshimitsu
    Kawai, Taketo
    Otsuka, Masafumi
    Miyakawa, Jimpei
    Uemura, Yukari
    Kanatani, Atsushi
    Taguchi, Satoru
    Naito, Akihiro
    Suzuki, Motofumi
    Nishimatsu, Hiroaki
    Hirano, Yoshikazu
    Tanaka, Yoshinori
    Matsumoto, Akihiko
    Miyazaki, Hideyo
    Fujimura, Tetsuya
    Fukuhara, Hiroshi
    Kume, Haruki
    Igawa, Yasuhiko
    Homma, Yukio
    WORLD JOURNAL OF UROLOGY, 2017, 35 (10) : 1569 - 1575
  • [42] Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study
    Tohru Nakagawa
    Yoshimitsu Komemushi
    Taketo Kawai
    Masafumi Otsuka
    Jimpei Miyakawa
    Yukari Uemura
    Atsushi Kanatani
    Satoru Taguchi
    Akihiro Naito
    Motofumi Suzuki
    Hiroaki Nishimatsu
    Yoshikazu Hirano
    Yoshinori Tanaka
    Akihiko Matsumoto
    Hideyo Miyazaki
    Tetsuya Fujimura
    Hiroshi Fukuhara
    Haruki Kume
    Yasuhiko Igawa
    Yukio Homma
    World Journal of Urology, 2017, 35 : 1569 - 1575
  • [43] NEOADJUVANT PLATINUM-BASED CHEMOTHERAPY FOR CLINICALLY NODE-POSITIVE PENILE SQUAMOUS CELL CARCINOMA: ANINTERNATIONAL, MULTICENTER, REAL-WORLD STUDY
    Rose, Kyle
    Sanchez, Darren
    Mustasam, Arfa
    Marchetti, Kathryn
    Sandstrom, Reagan
    Pagliaro, Lance
    Millward, Niki
    Alifrangis, Constantine
    Moses, Kelvin
    Albersen, Maarten
    Roussel, Eduard
    Master, Viraj
    Nazha, Bahzel
    Zhuang, Tony
    Montgomery, Jeffrey
    Protzel, Chris
    Tobias-Machado, Marcos
    Spiess, Philippe
    Pettaway, Curtis
    Chahoud, Jad
    JOURNAL OF UROLOGY, 2023, 209 : E451 - E452
  • [44] The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study)
    Longhao Xu
    Wenlong Zhong
    Chenchen Li
    Peng Hong
    Kun Xia
    Rongcheng Lin
    Sida Cheng
    Bo Wang
    Meng Yang
    Junyu Chen
    Lulin Ma
    Xuesong Li
    Liqun Zhou
    Jian Huang
    Tianxin Lin
    British Journal of Cancer, 2023, 128 : 310 - 320
  • [45] The tumour-associated stroma correlates with poor clinical outcomes and immunoevasive contexture in patients with upper tract urothelial carcinoma: results from a multicenter real-world study (TSU-01 Study)
    Xu, Longhao
    Zhong, Wenlong
    Li, Chenchen
    Hong, Peng
    Xia, Kun
    Lin, Rongcheng
    Cheng, Sida
    Wang, Bo
    Yang, Meng
    Chen, Junyu
    Ma, Lulin
    Li, Xuesong
    Zhou, Liqun
    Huang, Jian
    Lin, Tianxin
    BRITISH JOURNAL OF CANCER, 2023, 128 (02) : 310 - 320
  • [46] ONCOLOGICAL OUTCOMES IN PATIENTS WITH METASTATIC UROTHELIAL CARCINOMA AFTER DISCONTINUING PEMBROLIZUMAB AS A SECOND-LINE TREATMENT: A RETROSPECTIVE MULTICENTER REAL-WORLD COHORT STUDY
    Yamada, Toyohiro
    Tomioka, Risa
    Yokoyama, Tomohiro
    Sugino, Fumiya
    Kumada, Naoya
    Takeuchi, Shinichi
    Kawase, Makoto
    Takai, Manabu
    Kato, Daiki
    Iinuma, Koji
    Nakane, Keita
    Koie, Takuya
    JOURNAL OF UROLOGY, 2023, 209 : E439 - E439
  • [47] Oncological Outcomes in Patients with Metastatic Urothelial Carcinoma after Discontinuing Pembrolizumab as a Second-Line Treatment: A Retrospective Multicenter Real-World Cohort Study
    Yamada, Toyohiro
    Nakane, Keita
    Enomoto, Torai
    Tomioka, Masayuki
    Taniguchi, Tomoki
    Ishida, Takashi
    Ozawa, Kaori
    Takagi, Kimiaki
    Ito, Hiroki
    Takeuchi, Shinichi
    Kawase, Makoto
    Kawase, Kota
    Kato, Daiki
    Takai, Manabu
    Iinuma, Koji
    Yokoi, Shigeaki
    Nakano, Masahiro
    Koie, Takuya
    BIOMEDICINES, 2022, 10 (09)
  • [48] ASO Visual Abstract: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study
    Akihiko Okamura
    Masayuki Watanabe
    Jun Okui
    Satoru Matsuda
    Ryo Takemura
    Hirofumi Kawakubo
    Hiroya Takeuchi
    Manabu Muto
    Yoshihiro Kakeji
    Yuko Kitagawa
    Yuichiro Doki
    Annals of Surgical Oncology, 2023, 30 : 5897 - 5898
  • [49] Real-world eligibility for adjuvant CDK4/6 inhibitors among patients without genomic risk for chemotherapy: a GBECAM multicenter retrospective study
    Oliveira, Leandro
    Megid, Thais
    Rosa, Daniela
    Assad-Suzuki, Daniele
    Argolo, Daniel
    Sanches, Solange
    Testa, Laura
    Bines, Jose
    Kaliks, Rafael
    Gagliato, Debora
    Barroso-Sousa, Romualdo
    Correa, Tatiana
    Shimada, Andrea
    Batista, Daniel
    Musse, Daniel
    Cesca, Marcelle
    Gaudencio, Debora
    Moura, Larissa
    Araujo, Julio
    Bonadio, Renata Colombo
    Katz, Artur
    Mano, Max
    CANCER RESEARCH, 2024, 84 (09)
  • [50] Impact of adjuvant chemotherapy on oncologic outcomes following radical nephroureterectomy for patients with pT3NanyM0 upper tract urothelial carcinoma: A retrospective cohort study
    Song, Wan
    Jeong, Jae Yong
    Jeon, Hwang Gyun
    Seo, Seong Il
    Jeon, Seong Soo
    Choi, Han Yong
    Lee, Hyun Moo
    Sung, Hyun Hwan
    INTERNATIONAL JOURNAL OF SURGERY, 2019, 66 : 12 - 17
12345